potential treatment of COVID-19

Oryx Biotech to invest $300mn at Summit Technopolis for bio plant

Oryx Biotech, a subsidiary of Oryx Biotech Holdings based in China, signed a tripartite agreement with Summit Technopolis and BHTPA for a biotech investment worth USD 300 million in Bangladesh.

4 years ago